TRxADE HEALTH, Inc. (MEDS)
USD 7.59
(4.55%)
USD 7.59
(4.55%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 434.2 Thousand USD | -64.42% |
| 2022 | 1.22 Million USD | 14.06% |
| 2021 | 1.06 Million USD | 294.38% |
| 2020 | 271.3 Thousand USD | -70.2% |
| 2019 | 910.46 Thousand USD | 74.23% |
| 2018 | 522.55 Thousand USD | 29.33% |
| 2017 | 404.05 Thousand USD | 3716.49% |
| 2016 | 10.58 Thousand USD | -98.51% |
| 2015 | 708.38 Thousand USD | 0.0% |
| 2014 | - USD | 0.0% |
| 2013 | - USD | 0.0% |
| 2012 | - USD | 0.0% |
| 2008 | - USD | 0.0% |
| 2007 | - USD | 0.0% |
| 2006 | - USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 160.99 Thousand USD | 0.0% |
| 2024 Q1 | 168.97 Thousand USD | -100.0% |
| 2023 FY | 434.2 Thousand USD | -64.42% |
| 2023 Q2 | 776.56 Thousand USD | -6.72% |
| 2023 Q1 | 832.48 Thousand USD | -31.78% |
| 2023 Q4 | 434.2 Thousand USD | -56.66% |
| 2023 Q3 | 1 Million USD | 29.01% |
| 2022 Q2 | 1.32 Million USD | -2.56% |
| 2022 Q4 | 1.22 Million USD | -4.01% |
| 2022 FY | 1.22 Million USD | 14.06% |
| 2022 Q1 | 1.35 Million USD | 26.76% |
| 2022 Q3 | 1.27 Million USD | -3.8% |
| 2021 Q2 | 248 Thousand USD | -2.33% |
| 2021 FY | 1.06 Million USD | 294.38% |
| 2021 Q1 | 253.91 Thousand USD | -6.41% |
| 2021 Q4 | 1.06 Million USD | 342.23% |
| 2021 Q3 | 241.94 Thousand USD | -2.44% |
| 2020 Q2 | 861.08 Thousand USD | -2.82% |
| 2020 FY | 271.3 Thousand USD | -70.2% |
| 2020 Q1 | 886.07 Thousand USD | -2.68% |
| 2020 Q3 | 492.02 Thousand USD | -42.86% |
| 2020 Q4 | 271.3 Thousand USD | -44.86% |
| 2019 Q3 | 1 Million USD | -19.52% |
| 2019 FY | 910.46 Thousand USD | 74.23% |
| 2019 Q1 | 1.27 Million USD | 143.61% |
| 2019 Q2 | 1.25 Million USD | -1.58% |
| 2019 Q4 | 910.46 Thousand USD | -9.7% |
| 2018 Q1 | 404.05 Thousand USD | 0.0% |
| 2018 FY | 522.55 Thousand USD | 29.33% |
| 2018 Q3 | 222.55 Thousand USD | 0.0% |
| 2018 Q2 | 222.55 Thousand USD | -44.92% |
| 2018 Q4 | 522.55 Thousand USD | 134.8% |
| 2017 FY | 404.05 Thousand USD | 3716.49% |
| 2017 Q2 | 404.05 Thousand USD | 0.0% |
| 2017 Q3 | 404.05 Thousand USD | 0.0% |
| 2017 Q1 | - USD | -100.0% |
| 2017 Q4 | 404.05 Thousand USD | 0.0% |
| 2016 Q2 | 943.72 Thousand USD | 29.39% |
| 2016 FY | 10.58 Thousand USD | -98.51% |
| 2016 Q4 | 10.58 Thousand USD | -98.95% |
| 2016 Q3 | 1 Million USD | 6.68% |
| 2016 Q1 | 729.37 Thousand USD | 2.96% |
| 2015 Q3 | - USD | 0.0% |
| 2015 Q2 | - USD | 0.0% |
| 2015 Q1 | - USD | 0.0% |
| 2015 FY | 708.38 Thousand USD | 0.0% |
| 2015 Q4 | 708.38 Thousand USD | 0.0% |
| 2014 Q1 | - USD | 0.0% |
| 2014 Q3 | - USD | 0.0% |
| 2014 Q2 | - USD | 0.0% |
| 2014 FY | - USD | 0.0% |
| 2014 Q4 | - USD | 0.0% |
| 2013 Q4 | - USD | 0.0% |
| 2013 FY | - USD | 0.0% |
| 2013 Q1 | - USD | 0.0% |
| 2012 FY | - USD | 0.0% |
| 2009 Q2 | - USD | 0.0% |
| 2009 Q1 | - USD | 0.0% |
| 2009 Q3 | - USD | 0.0% |
| 2008 Q2 | - USD | 0.0% |
| 2008 Q3 | - USD | 0.0% |
| 2008 Q4 | - USD | 0.0% |
| 2008 FY | - USD | 0.0% |
| 2008 Q1 | - USD | 0.0% |
| 2007 Q3 | - USD | 0.0% |
| 2007 Q4 | - USD | 0.0% |
| 2007 Q2 | - USD | 0.0% |
| 2007 FY | - USD | 0.0% |
| 2006 FY | - USD | 0.0% |
| 2006 Q4 | - USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| CannBioRx Life Sciences Corp. | 19.93 Thousand USD | -2077.995% |
| BIMI International Medical Inc. | 2.88 Million USD | 84.973% |
| China Jo-Jo Drugstores, Inc. | 6.4 Million USD | 93.22% |
| Harrow Health, Inc. 8.625% Senior Notes due 2026 | 183.17 Million USD | 99.763% |
| Harrow Health, Inc. 11.875% Senior Notes due 2027 | 183.17 Million USD | 99.763% |
| Leafly Holdings, Inc. | 29.08 Million USD | 98.507% |
| Leafly Holdings, Inc. | 29.08 Million USD | 98.507% |
| LifeMD, Inc. | 17.92 Million USD | 97.578% |
| LifeMD, Inc. | 17.92 Million USD | 97.578% |
| PetMed Express, Inc. | 995 Thousand USD | 56.361% |
| Walgreens Boots Alliance, Inc. | 8.04 Billion USD | 99.995% |